Applied Therapeutics, Inc.
APLT
$0.3692
$0.00541.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -100.00% | |||
| Cost of Revenue | -32.99% | -21.13% | |||
| Gross Profit | 32.99% | 20.47% | |||
| SG&A Expenses | -17.06% | 41.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.70% | 10.57% | |||
| Operating Income | 22.70% | -11.02% | |||
| Income Before Tax | -149.59% | 164.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -149.59% | 164.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -149.59% | 164.16% | |||
| EBIT | 22.70% | -11.02% | |||
| EBITDA | 22.70% | -11.02% | |||
| EPS Basic | -149.47% | 164.10% | |||
| Normalized Basic EPS | -149.47% | 164.13% | |||
| EPS Diluted | -149.95% | 163.49% | |||
| Normalized Diluted EPS | -149.47% | 164.13% | |||
| Average Basic Shares Outstanding | 0.23% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.23% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||